- Issuing authority
- Emirates Drug Authority
- Jurisdiction
- United Arab Emirates
- Publication date
- November 19, 2026
- Stage
- Final rule
- Official source
- news.google.com
The Emirates Drug Authority has reinforced regulations governing medical advertisements, emphasizing that prior official approval must be obtained before publishing or distributing promotional material across the UAE, Emirates 24|7 reported. The authority specified that regulations govern claims and promotional practices, explicitly prohibiting the advertising or promotion of medical products through social media influencers.
The directives were detailed during the Medical Products Advertising Council, convened at the Government Accelerators Centre in Emirates Towers, Dubai. The meeting brought together industry representatives, partners, and stakeholders to raise awareness of statutory approval requirements and ensure compliance with updated regulatory frameworks for promotional content.
The review covered regulations for prescription drug advertising across various media, including print, audio, visual formats, outdoor screens, websites, social media platforms, and other digital channels. Stakeholders discussed procedures for submitting approval requests via the electronic system, the submission documents required by advertising medium, and the review stages for audio-visual content.
Under the guidelines, advertising content must remain clear, accurate, and aligned strictly with approved product data and indications while avoiding misleading claims. Disclosures of side effects, risks, and required warnings must be presented based on the product category and target audience, and advertising must not encourage the public to self-diagnose or administer treatments without medical supervision.
Sources
- Emirates 24|7 · 2026-11-19



